List view / Grid view

Gedeon Richter

 

news

FDA approves Vraylar for schizophrenia and bipolar disorder

The FDA approval is based on the results of three…

21 September 2015 | By Victoria White

The FDA approval is based on the results of three 3-week controlled trials in adults with bipolar I disorder and three 6-week placebo-controlled trials in adults with schizophrenia...